Skip to Main Content

Author Details

Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
1982
423
85
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36871660Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.J Invest Dermatol2023
37608799ZENBU-Reports: a graphical web-portal builder for interactive visualization and dissemination of genome-scale data.NAR Genom Bioinform2023
36871660Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.J Invest Dermatol2023
37608799ZENBU-Reports: a graphical web-portal builder for interactive visualization and dissemination of genome-scale data.NAR Genom Bioinform2023
33950411Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy.Clin Exp Metastasis2022
35906708Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.Clin Epigenetics2022
35840558Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy.Nat Commun2022
35839317UBQLN4 promotes STING proteasomal degradation during cisplatin-induced DNA damage in triple-negative breast cancer.Clin Transl Med2022
36230675Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients' Blood.Cancers (Basel)2022
35961773Deep sequencing of short capped RNAs reveals novel families of noncoding RNAs.Genome Res2022
36291176Genomic Amplification of <i>UBQLN4</i> Is a Prognostic and Treatment Resistance Factor.Cells2022
35501311Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.Cell Death Dis2022
35878022IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.Proc Natl Acad Sci U S A2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
35625992Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.Cancers (Basel)2022
35561684Topical therapy for regression and melanoma prevention of congenital giant nevi.Cell2022
36125262DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness.Elife2022
36577377Antisense-oligonucleotide-mediated perturbation of long non-coding RNA reveals functional features in stem cells and across cell types.Cell Rep2022
33950411Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy.Clin Exp Metastasis2022
35031134Prognostic Utility of CpG Island Hypermethylated Phenotype in Early-Stage Invasive Primary Melanomas.J Invest Dermatol2022
35205608Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients.Cancers (Basel)2022
35190823Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.Clin Cancer Res2022
34489601Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19.Nat Biotechnol2022
35013528Cell-free plasma microRNAs that identify patients with glioblastoma.Lab Invest2022
35121729Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.Cell Death Dis2022
35840558Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy.Nat Commun2022
35839317UBQLN4 promotes STING proteasomal degradation during cisplatin-induced DNA damage in triple-negative breast cancer.Clin Transl Med2022
35501311Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.Cell Death Dis2022
35625992Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.Cancers (Basel)2022
35561684Topical therapy for regression and melanoma prevention of congenital giant nevi.Cell2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
36577377Antisense-oligonucleotide-mediated perturbation of long non-coding RNA reveals functional features in stem cells and across cell types.Cell Rep2022
35906708Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.Clin Epigenetics2022
35961773Deep sequencing of short capped RNAs reveals novel families of noncoding RNAs.Genome Res2022
36230675Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients' Blood.Cancers (Basel)2022
36125262DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness.Elife2022
36291176Genomic Amplification of <i>UBQLN4</i> Is a Prognostic and Treatment Resistance Factor.Cells2022
35878022IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.Proc Natl Acad Sci U S A2022
35190823Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.Clin Cancer Res2022
35013528Cell-free plasma microRNAs that identify patients with glioblastoma.Lab Invest2022
35121729Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.Cell Death Dis2022
35031134Prognostic Utility of CpG Island Hypermethylated Phenotype in Early-Stage Invasive Primary Melanomas.J Invest Dermatol2022
35205608Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients.Cancers (Basel)2022
34489601Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19.Nat Biotechnol2022
33211864FANTOM enters 20th year: expansion of transcriptomic atlases and functional annotation of non-coding RNAs.Nucleic Acids Res2021
34078885Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network.Nat Commun2021
33704735Assessment of Cell-Free microRNA by NGS Whole-Transcriptome Analysis in Cutaneous Melanoma Patients' Blood.Methods Mol Biol2021
33966052EpiMap: Fine-tuning integrative epigenomics maps to understand complex human regulatory genomic circuitry.Signal Transduct Target Ther2021
34117054Vitamin D deficiency exacerbates UV/endorphin and opioid addiction.Sci Adv2021
34011993Author Correction: RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions.Nat Commun2021
  • 1 - 50 of 846

Recommended Authors

Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 5
Mitchell P Levesque
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 18
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 4
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2006
Number of shared co-authors 6
Harriet M Kluger
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 13
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 12
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 3
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 2
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 1
Yardena Samuels
Weizmann Institute of Science
Career Start Year 1998
Number of shared co-authors 19
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Hae-Ock Lee
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 4
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 10
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 2
Timothy A Chan
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 19
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Career Start Year 1993
Number of shared co-authors 10
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 1
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 16
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 7
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 24
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 8
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 1
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 13
Nicholas K Hayward
QIMR Berghofer Medical Research Institute
Career Start Year 1982
Number of shared co-authors 27
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 20
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 11

Collaborators

Donald L Morton
Co-authored papers 93
Yoshihide Hayashizaki
Center for Integrative Medical Sciences
Co-authored papers 39
Piero Carninci
RIKEN Center for Integrative Medical Sciences
Co-authored papers 36
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 22
Harukazu Suzuki
RIKEN Center for Integrative Medical Sciences
Co-authored papers 22
Hideya Kawaji
RIKEN Center for Integrative Medical Sciences
Co-authored papers 21
Kelly K Chong
Co-authored papers 21
Alistair R R Forrest
RIKEN Center for Integrative Medical Sciences
Co-authored papers 20
Erik Arner
RIKEN Center for Integrative Medical Sciences (IMS)
Co-authored papers 19
Carsten O Daub
International Institute of Molecular and Cell Biology in Warsaw
Co-authored papers 18
Masayoshi Itoh
RIKEN Center for Integrative Medical Sciences
Co-authored papers 18
Timo Lassmann
Telethon Kids Institute, University of Western Australia
Co-authored papers 18
Jessica Severin
Center for Integrative Medical Sciences
Co-authored papers 16
Jay W Shin
Genome Institute of Singapore (GIS)
Co-authored papers 15
Takeya Kasukawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 14
Richard A Scolyer
Co-authored papers 12
Cornelis J H van de Velde
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Co-authored papers 11
Qiang Yu
Co-authored papers 11
Marina Lizio
Cerevance Ltd
Co-authored papers 10
Jordan A Ramilowski
Advanced Medical Research Center, Yokohama City University
Co-authored papers 10
Akira Hasegawa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 9
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Imad Abugessaisa
RIKEN Center for Integrative Medical Sciences
Co-authored papers 9
Albin Sandelin
University of Copenhagen
Co-authored papers 9
Robin Andersson
University of Copenhagen
Co-authored papers 8
Chung-Chau Hon
RIKEN center for Integrative Medical Sciences, Hiroshima University
Co-authored papers 8
Nicolas Bertin
University Bordeaux, CNRS
Co-authored papers 8
Yuri Ishizu
RIKEN Center for Life Science Technologies
Co-authored papers 8
Tung T Nguyen
Co-authored papers 8
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 7
Release 1.2